Exploring Non-Factor Replacement Therapies for Hemophilia Care

Achieving Positive Outcomes

Register Now
  • Tuesday, July 30, 2024
  • 12:30 pm - 1:00 pm ET
  • CME/CNE/CPE
  • Virtual
Overview

Non-factor replacement therapies – therapies that seek to address bleeding issues without replacing the missing factor – offer a new model for hemophilia care. There is currently one approved agent and many others under investigation that approach hemostasis differently. Join our experts as they discuss the current state of research into non-factor replacement therapies while exploring optimal communication with patients regarding the potential use of these new approaches.
Register Now
Speakers
Speaker Image
Stacy Croteau, MD, MMS

Medical Director

Boston Bleeding Disorders Center

Assistant Professor of Pediatrics

Harvard Medical School

Boston, Massachusetts

Speaker Image
Regina Butler, RN-BC

Clinical Manager

Division of Hematology Nurse Coordinator

CHOP Hemostasis and Thrombosis Center

Philadelphia, Pennsylvania

Agenda

Introduction to Non-Factor Replacement Therapies

Current and Emerging Therapeutic Options

Practical Considerations

Audience Q&A

Register Now
Program Information
Accreditation Statement

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Accreditation logos
Accreditation logos
For Physicians

Medscape, LLC designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses

Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs.

For Pharmacists

Medscape designates this continuing education activity for 0.5 contact hour(s) (0.050 CEUs) (Universal Activity Number: JA0007105-0000-24-226-L01-P).

Learning Objectives

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the evidence supporting the development and use of non-factor replacement therapies for treatment of hemophilia
  • Have greater competence related to incorporating non-factor replacement therapies for the treatment of hemophilia
  • Demonstrate greater confidence in their ability to use effective communication strategies to develop individualized care plans
Goal Statement
The goal of this activity is for learners to be better able to recognize and integrate the dynamic evidence evaluating non-factor replacement therapies into the clinical care of patients with hemophilia.
Target Audience
This activity is intended for hematologist/oncologists, pediatricians, primary care physicians, emergency medicine physicians, nurses, pharmacists, and other members of the comprehensive hemophilia care team.

Supported by an independent educational grant from Novo Nordisk..